Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Vaughan Nelson Investment Management L.P.

Vaughan Nelson Investment Management L.P. lowered its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 71.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 28,478 shares of the biotechnology company's stock after selling 72,705 shares during the quarter. Vaughan Nelson Investment Management L.P.'s holdings in Axon Enterprise were worth $14,978,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after buying an additional 275,959 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock valued at $1,095,542,000 after buying an additional 65,097 shares in the last quarter. Capital World Investors increased its position in shares of Axon Enterprise by 86.4% in the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock valued at $1,079,145,000 after buying an additional 841,772 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of Axon Enterprise by 273.8% in the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after buying an additional 812,337 shares in the last quarter. Finally, Norges Bank purchased a new position in shares of Axon Enterprise in the fourth quarter valued at $482,081,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on AXON. Bank of America raised their price target on Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. The Goldman Sachs Group raised their price target on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Needham & Company LLC lifted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. Finally, Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $699.55.

Axon Enterprise Stock Up 0.7%

Shares of NASDAQ:AXON opened at $780.63 on Monday. The stock's 50-day moving average price is $669.47 and its two-hundred day moving average price is $621.44. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $279.02 and a 12-month high of $806.64. The firm has a market cap of $60.77 billion, a price-to-earnings ratio of 201.71, a PEG ratio of 5.17 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same period last year, the company earned $1.15 EPS. The firm's quarterly revenue was up 31.3% on a year-over-year basis. On average, research analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Insider Activity

In other news, Director Michael Garnreiter sold 87 shares of Axon Enterprise stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $760.00, for a total value of $66,120.00. Following the transaction, the director now directly owns 24,653 shares of the company's stock, valued at $18,736,280. The trade was a 0.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, President Joshua Isner sold 9,000 shares of Axon Enterprise stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $683.31, for a total value of $6,149,790.00. Following the completion of the transaction, the president now directly owns 308,714 shares in the company, valued at $210,947,363.34. This represents a 2.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,662 shares of company stock valued at $29,739,909 in the last three months. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.